Seeking Alpha

Today's weakness in DaVita (DVA -1.7%) shares perhaps is attributable to a NY Times article...

Today's weakness in DaVita (DVA -1.7%) shares perhaps is attributable to a NY Times article describing how a shift by the U.S. government in how it pays for drugs to treat dialysis patients may have resulted in a jump in blood transfusions for patients who now may not be getting enough of the medications.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|